HBME-1 IHC Test for Thyroid Tumors | Lahalak Platform
A precise test to differentiate between benign and malignant tumors in the thyroid and serous tissues, aiding in highly accurate diagnosis.
Scientific name: HBME-1 Immunohistochemistry Test
Immunohistochemical testing for HBME-1 (Human Bone Marrow Endothelial Cell-1) aims to detect this antigen on the surface of mesothelial cells (cells lining serous cavities such as the pleura and peritoneum) and in the epithelial cells of certain tumors. It is primarily used as an aid in the diagnosis of papillary thyroid carcinoma (PTC) and to diff...
Service type
Histopathology Laboratory Test
Duration
30-45 minutes
Fasting
Fasting is not required
Included Services
- Accurate analysis for the detection of HBME-1 antigen in tissue or cell samples (FNA cell mass)
- Consult a pathologist to interpret the results.
- Personal support services from Lahalak
Medical Service Information
Conditions & Notices
- Fasting is not required, as the sample is tissue or cell-based.
- For fine-needle aspiration (FNA) thyroid biopsies, the sample must be converted into a cell block to enable IHC to be performed on it.
- This analysis is usually requested as part of a diagnostic package for thyroid nodules (with Galectin-3, CK19) or mesotheliomas package.
- The location of the sample and the diagnostic target must be clearly defined (distinguishing PTC from benign, or distinguishing mesothelioma from metastasis).
Medical services you might also like
